The table below shows ACADIA PHARMACEUTICALS INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$268.06M
$278.63M
$264.57M
$244.32M
$250.40M
$241.96M
Cost of revenue
$24.79M
$21.65M
$20.73M
$20.39M
$18.86M
$18.23M
Gross profit
-
-
-
-
-
-
R&D
$76.87M
$87.83M
$77.95M
$78.27M
$66.61M
$76.23M
ACAD annual revenue (10-K history)
ACADIA PHARMACEUTICALS INC reported annual revenue of $1.07B for fiscal year 2025. That is up 11.9% from $957.80M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $17.33M (FY 2016) to $1.07B. Figures come from the company's audited annual reports as filed with the SEC.
